-

08:06:23 PM

HLTH Stock News

HLTH - Cue Health Inc

12/01/21 9:15 AM

Nasdaq : HLTH

covid-19

Cue Health Receives Singapore HSA Authorization for its Molecular COVID-19 Test for Self-Testing

Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced it received Pandemic Special Access Route (PSAR) authorization from the Health Sciences Authority (HSA) for the Cue COVID-19 Test for self-testing in Singapore. The Cue

RHEA-AI

very positive

11/29/21 9:15 AM

Nasdaq : HLTH

covid-19

Cue Health Confirms COVID-19 Tests Can Detect Omicron Variant

Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced it has completed an analysis of the SARS-CoV-2 B.1.1.529 variant, designated by the World Health Organization as Omicron. Using information from the GISAID database, Cue has

RHEA-AI

positive

11/18/21 9:15 AM

Nasdaq : HLTH

covid-19

Helix and Cue Health Collaborate to Provide Individuals with Access to their COVID-19 Variant Sequencing Information

Helix, a leading genomics company that provides nationwide viral surveillance of respiratory disease, and Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, announced a new collaboration today to provide individuals who

RHEA-AI

positive

11/10/21 4:01 PM

Nasdaq : HLTH

earnings

Cue Health Reports Third Quarter 2021 Financial Results

Cue Health Inc., a mission-driven healthcare technology company, today reported financial results for the third quarter ended September 30, 2021. Reported record total revenue of $223.7 million for the third quarter of 2021, a 63% increase compared to the second quarter of 2021 Public sector revenue of $129.5 million, up 23% for the third quarter of 2021...

RHEA-AI

neutral

11/09/21 5:00 AM

Nasdaq : HLTH

covid-19

Cue Health To Launch Direct-To-Consumer Virtual Health Platform Featuring Its COVID-19 Self-Test Trusted By Google, Mayo Clinic, The NBA, And MLB

Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that its direct-to-consumer (DTC) virtual health platform will launch on November 15th, making Cue's first-of-its-kind molecular COVID-19 test available to people across the

RHEA-AI

very positive

11/01/21 9:15 AM

Nasdaq : HLTH

covid-19

Cue Health Provides Molecular COVID-19 Testing To MLB Clubs During The Postseason And World Series

Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, and Major League Baseball (MLB) today announced that Cue has been providing all Clubs, as well as the league office, with its integrated Cue platform, which features both

RHEA-AI

neutral

10/27/21 4:01 PM

Nasdaq : HLTH

earnings

Cue Health to Announce Third Quarter 2021 Financial Results

Cue Health Inc., a healthcare technology company, announced today that it will release its third quarter 2021 financial results on Wednesday, November 10, 2021. About Cue Health Cue Health is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care.

RHEA-AI

neutral

10/14/21 9:15 AM

Nasdaq : HLTH

covid-19

Cue Health To Provide COVID-19 Testing For 2021-22 NBA Season

Cue Health Inc. (Nasdaq: HLTH), a mission-driven healthcare technology company, and the National Basketball Association (NBA) today announced that Cue will serve as the league's Official Home and Point of Care Test for the 2021-22 season. The

RHEA-AI

neutral

10/06/21 9:15 AM

Nasdaq : HLTH

Cue Health Collaborates With Google Cloud To Add Variant Sequencing, Tracking, And Predictive Capabilities To Its Cue Platform

Cue Health Inc. (Nasdaq: HLTH), a mission-driven healthcare technology company, today introduced its new collaboration with Google Cloud to address the nation's critical need for real-time respiratory viral variant sequencing and tracking. The new

RHEA-AI

neutral

09/23/21 8:59 PM

Nasdaq : HLTH

IPOoffering

Cue Health Announces Pricing of Initial Public Offering

Cue Health Inc. ("Cue Health") (Nasdaq: HLTH), a health technology company, today announced the pricing of its initial public offering of 12,500,000 shares of its common stock at a public offering price of $16.00 per share, for gross proceeds of $200.0

RHEA-AI

neutral